Story · Medicine & Biotech

Successful Lipid Lowering With Alirocumab and Bempedoic Acid in a Statin-Intolerant Heterozygous Familial Hypercholesterolemia With Markedly Elevated Lipoprotein(a): A Case Report

1 outlet · first reported by Cureus on

Intensive lipid lowering is essential in the management of heterozygous familial hypercholesterolaemia (HeFH). Statin intolerance necessitates consideration of alternative lipid-lowering therapies, while concomitantly elevated lipoprotein(a) (Lp(a)) further increases cardiovascular risk and the… (Cureus)

Coverage, in order

  1. Cureus indie study
    Successful Lipid Lowering With Alirocumab and Bempedoic Acid in a Statin-Intolerant Heterozygous Familial Hypercholesterolemia With Markedly Elevated Lipoprotein(a): A Case Report

    Intensive lipid lowering is essential in the management of heterozygous familial hypercholesterolaemia (HeFH). Statin intolerance necessitates consideration of alternative lipid-lowering therapies, while concomitantly elevated lipoprotein(a) (Lp(a)) further increases cardiovascular risk and the…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.